EBAC European Biotech Acquisition PE ratio, current and historical analysis
As of Mar 2, 2023, the EBAC stock has a PE ratio of 559.5. The calculation is based on the latest EPS of $0.02 and the stock price of $11.19 per share.
EBAC PE ratio history
The mean historical PE ratio of European Biotech Acquisition over the last four years is 174.26. The current 559.5 price-to-earnings ratio is in line with the historical average. Analyzing the last four years, EBAC's PE ratio reached its highest point in the Dec 2022 quarter at 505, with a price of $10.1 and an EPS of $0.02. The Sep 2021 quarter saw the lowest point at 64.47, with a price of $9.67 and an EPS of $0.15.
European Biotech Acquisition PE ratio by year
Maximum annual increase: 473.28% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2022 | 505 | 473.28% | $10.1 | $0.02 |
| 2021 | 88.09 | N/A | $9.69 | $0.11 |
European Biotech Acquisition PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2022 | 505 | 103.83% | $10.1 | $0.02 |
| Sep 2022 | 247.75 | 228.97% | $9.91 | $0.04 |
| Jun 2022 | 75.31 | 15.99% | $9.79 | $0.13 |
| Mar 2022 | 64.93 | -26.29% | $9.74 | $0.15 |
| Dec 2021 | 88.09 | 36.64% | $9.69 | $0.11 |
| Sep 2021 | 64.47 | N/A | $9.67 | $0.15 |
| Jun 2021 | N/A | N/A | $9.74 | N/A |
| Mar 2021 | N/A | N/A | $10.07 | N/A |
| Jan 2021 | N/A | N/A | N/A | N/A |
EBAC average PE ratio chart
EBAC PE vs peers
EBAC's PE ratio is above its peer stocks OCSL and OFS.
| Stock name | PE ratio | Market cap |
|---|---|---|
| OFS OFS Capital Corp | 4.29 | $121.99M |
| OCSL Oaktree Specialty Lending Corp | 22.1 | $1.24B |
| EBAC European Biotech Acquisition Corp | 559.5 | $183.5M |
Frequently asked questions
What is European Biotech Acquisition's PE ratio?
EBAC's price to earnings ratio is 559.5 as of Mar 2, 2023.
What is the highest PE ratio for EBAC?
The current PE of 559.5 represents the highest historical value in the last four years.
How does the current PE ratio for EBAC compare to its historical average?
EBAC's current price to earnings ratio is 221% above its 4-year historical average.
Why is European Biotech Acquisition's PE ratio so high?
EBAC's PE ratio is high because the stock price is relatively expensive compared to the earnings generated by the company.
How is EBAC's PE ratio calculated (European Biotech Acquisition PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Mar 2, 2023), European Biotech Acquisition's share price is $11.19. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2022 is $0.02. Therefore, European Biotech Acquisition's price to earnings ratio for today is 559.5. PE RATIO(559.5) = STOCK PRICE($11.19) / TTM EPS($0.02)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.